Gene Targeting & Transgenic Shared Resource
Gene Targeting & Transgenic Shared Resource
批准号:
9923571
负责人:
Eugene Yu
金额:
$8.34万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Animal ModelAreaBacterial Artificial ChromosomesBiophysicsBreedingCRISPR/Cas technologyCancer Center Support GrantCancer ModelCellular StressChargeClinicalClustered Regularly Interspaced Short Palindromic RepeatsCohort AnalysisCommunitiesComplexConsultationsCryopreservationDNA biosynthesisData SetDevelopmentDevelopmental Therapeutics ProgramElectroporationEmbryoEnsureEnvironmentFaculty RecruitmentFundingFutureGene TargetingGenerationsGeneticGenetic EngineeringGenetically Engineered MouseGenomicsGenotypeGlycobiologyGoalsGonadal structureHuman GenomeIn VitroIndividualIndustry CollaborationLaboratoriesMalignant NeoplasmsMalignant neoplasm of pancreasMalignant neoplasm of prostateMalignant neoplasm of urinary bladderMammalian OviductsMethodsMissionMusMutationNamesPathogenesisPathway interactionsPeer ReviewPhenotypeProductionReportingResearchResearch PersonnelResource SharingResourcesRunningScientistServicesSourceTechniquesTechnologyTraining and EducationTransgenic MiceTransgenic OrganismsWorkbasecost effectivedesign and constructionembryonic stem cellexperiencegenome editingimprovedin vivoinstrumentationknockout genemalignant breast neoplasmmammalian genomemembermouse genomemouse modelmutantneoplasm immunotherapynew technologynovelnucleic acid deliveryprogramstrendtumortumor immunology
中文摘要
基因靶向和转基因共享资源(GeTT)的使命是确保罗斯威尔公园
CCSG成员可以获得最先进的转基因小鼠技术、方法和动物模型。
随着现代哺乳动物基因组操作技术的发展,
小鼠已经成为新的癌症模型的来源,这些模型有助于阐明导致肿瘤的途径。
发展和进步。GeTT已经产生了超过1,000种新的基因工程小鼠品系,
CCSG计划成员。最近引入的CRISPR/Cas9基因组编辑技术
大大提高了生成新小鼠模型的效率,并使一些关键的新研究成为可能。
罗斯威尔公园的调查员进行了调查在报告所述期间(2013-
2017年),GeTT共为47个Roswell用户提供服务,其中42个(89%)是CCSG成员。一般来说,GeTT
向其CCSG成员收取的费用约为商业公司转基因产品收费的三分之一。
基因改造小鼠资源主任和共同主任从最早期起就向调查人员提供指导
当构造设计到项目的后期阶段时,
表型分析资源技术人员执行专门的ES细胞和胚胎操作方法
来制造基因工程小鼠。需要开发转基因小鼠模型的项目
正变得越来越相关,以验证来自体外研究和高通量临床研究的发现,
基于数据集。GeTT的具体目标是:1)为了确保罗斯威尔公园CCSG成员,
获得最先进的转基因方法,技术和小鼠模型; 2)作为“一站式”
与遗传工程有关的咨询、教育、培训和专家支持的共享资源
小鼠模型; 3)与罗斯韦尔公园的其他共享资源协同工作,以提供优化的
为CCSG成员提供研究环境。GeTT在提供所有必要的
技术和服务,以实现目标。GeTT未来的计划是增加
通过优化几种新的基于CRISPR的基因组编辑,
技术. GeTT目前正在开发新的技术,如CRISPR和GONAD(Gonadal
核酸递送的输卵管转移)。此外,GeTT最近开发了一项服务,
CCSG成员实验室的小鼠群体管理,这些实验室之前没有复杂小鼠的经验
用于队列分析的育种。
英文摘要
The mission of the Gene Targeting and Transgenic Shared Resource (GeTT) is to ensure that Roswell Park
CCSG members have access to state-of-the-art transgenic mouse technologies, methods and animal models.
With the development of contemporary mammalian genome manipulation technologies, genetically engineered
mice have become a source of new cancer models that have helped elucidate pathways contributing to tumor
development and progression. GeTT has generated over 1,000 novel genetically engineered mouse lines for
CCSG program members. The recent introduction of CRISPR/Cas9 genome editing technologies has
drastically improved the efficiency of generating new mouse models, and enabled some critical new research
by Roswell Park investigators that would not have been otherwise possible. In the reporting period (2013-
2017), the GeTT served a total of 47 Roswell users, of which 42 (89%) were CCSG members. Typically, GeTT
charges its CCSG members ~one-third of what commercial companies would charge to create genetically
engineered mice. The Resource Director and Co-Director provide guidance to investigators from the earliest
planning stages of the project when constructs are designed to advanced stages of the project during
phenotype analysis. Resource technicians perform the specialized ES cell and embryo manipulation methods
to generate the genetically engineered mice. Projects requiring the development of transgenic mouse models
are becoming increasingly relevant to validate findings from in vitro studies and from high-throughput clinical-
based datasets. The Specific Aims of the GeTT are: 1) To ensure that Roswell Park CCSG members, have
access to state-of-the-art transgenic methods, technologies, and mouse models; 2) To serve as a “one-stop”
Shared Resource for consultation, education, training and expert support related to genetic engineering of
mouse models; 3) To work synergistically with other shared resources at Roswell Park to provide the optimized
research environment for CCSG members. The GeTT has significant expertise in providing all the necessary
technologies and services to achieve the objectives of the Aims. The GeTT future plan is to increase the
number of CCSG members utilizing the GeTT by optimizing several new CRISPR-based genome-editing
techniques. GeTT is currently developing new techniques such as Easi-CRISPR and GONAD (Gonadal
oviductal transfer of Nucleic Acid Delivery). In addition GeTT has recently developed a service that offers
mouse colony management to CCSG member labs who do not have previous experience in complex mouse
breeding for cohort analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CRISPR-mediated engineering and pilot study of mouse mutants of the bitter taste receptor genes
-
批准号:10451169
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2022
-
负责人:Eugene Yu
-
依托单位:
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits
-
批准号:10704099
-
项目类别:
-
资助金额:$46.07万
-
财政年份:2022
-
负责人:Eugene Yu
-
依托单位:
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits
-
批准号:10518886
-
项目类别:
-
资助金额:$47.58万
-
财政年份:2022
-
负责人:Eugene Yu
-
依托单位:
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits
-
批准号:10711887
-
项目类别:
-
资助金额:$43.8万
-
财政年份:2022
-
负责人:Eugene Yu
-
依托单位:
Mutational analysis to understand the role of CHML in developmental regression
-
批准号:8877784
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2015
-
负责人:Eugene Yu
-
依托单位:
Mutational analysis to understand the role of CHML in developmental regression
-
批准号:9069905
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2015
-
负责人:Eugene Yu
-
依托单位:
Genetic Dissection of Trisomy 21
-
批准号:8066350
-
项目类别:
-
资助金额:$43.22万
-
财政年份:2008
-
负责人:Eugene Yu
-
依托单位:
Genetic Dissection of Trisomy 21
-
批准号:7585303
-
项目类别:
-
资助金额:$42.22万
-
财政年份:2008
-
负责人:Eugene Yu
-
依托单位:
Genetic Dissection of Trisomy 21
-
批准号:8249053
-
项目类别:
-
资助金额:$43.31万
-
财政年份:2008
-
负责人:Eugene Yu
-
依托单位:
Genetic Dissection of Trisomy 21
-
批准号:7781344
-
项目类别:
-
资助金额:$42.78万
-
财政年份:2008
-
负责人:Eugene Yu
-
依托单位:
Gene Targeting & Transgenic Shared Resource
-
批准号:10641712
-
项目类别:
-
资助金额:$7.68万
-
财政年份:1997
-
负责人:Eugene Yu
-
依托单位:
Gene Targeting & Transgenic Shared Resource
-
批准号:10398050
-
项目类别:
-
资助金额:$8.08万
-
财政年份:1997
-
负责人:Eugene Yu
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: